Kento Morozumi

9PUBLICATIONS
10CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical devicesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
Intestinal obstruction due to internal hernia with dual defects following laparoscopic retroperitoneal tumor resection: a case report.

|Apr 23, 2026
Editorial Comments on PTHrP-Producing Renal Cell Carcinoma Presenting as Rapidly Progressive Cognitive Impairment: A Case Report.

|Apr 17, 2026
Oncologic Outcomes of Cytoreductive Radical Prostatectomy in Patients With Synchronous Metastatic Castration-Sensitive Prostate Cancer: A Retrospective Analysis.

|Sep 02, 2024
Treatment strategies for revision surgery of artificial urinary sphincter: A review.

Yasuhiro Kaiho, Masaaki Oikawa, Hiroki Kusumoto

|Mar 27, 2024
Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism.

Kento Morozumi, Yoshihide Kawasaki, Tomonori Sato

|Jan 18, 2022
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.

Kento Morozumi, Koji Mitsuzuka, Shintaro Narita

Pageof 2

Frequent Collaborators

2 joint publications

Yoshihide Kawasaki

1 joint publications

Vladimir Bilim

1 joint publications

Tomonori Sato

1 joint publications

Koji Mitsuzuka